Table 4 Demographical, laboratory, and treatment features of type 1 (T1D), type 2 (T2D) and gestational (GDM) diabetic patients
Subjects | Age (years) | Gender | Insulin regular/NPH | Duration of diabetes (years) | Blood glucose (mg/dL) | Glycated hemoglobin (%) | Metformin (mg/day) | Duration of pregnancy (weeks) |
|---|---|---|---|---|---|---|---|---|
T1DM-02 | 23 | M | Yes | 13 | 197 | 8.3 | - | - |
T1DM-03 | 24 | M | Yes | 6 | 260 | 10 | - | - |
T1DM-04 | 18 | M | Yes | 8 | 23 | 7.2 | - | - |
T1DM-05 | 23 | M | Yes | 20 | 178 | 10.1 | - | - |
T1DM-06 | 21 | F | Yes | 8 | 223 | 7.8 | - | - |
T1DM-12 | 27 | F | Yes | 10 | 257 | 10.4 | - | - |
T1DM-15 | 22 | F | Yes | 13 | 143 | 8.3 | - | - |
Mean ± SD | 22.57 ± 2.76 |  |  | 11.14 ± 4.70 | 183 ± 82.08 | 8.87 ± 1.27 |  |  |
T2DM-04 | 49 | M | No | 8 | 130 | 7.5 | 2550 | - |
T2DM-05 | 42 | M | Yes | 11 | 53 | 5.1 | 1700 | - |
T2DM-09 | 52 | M | No | 10 | 100 | 6.6 | 1700 | - |
T2DM-11 | 41 | F | Yes | 3 | 92 | 10.2 | 2550 | - |
T2DM-12 | 43 | F | No | 4 | 173 | 10.7 | 2550 | - |
T2DM-13 | 60 | F | Yes | 20 | 306 | 10.9 | 0 | - |
T2DM-16 | 56 | F | Yes | 20 | 295 | 12 | 2550 | - |
T2DM-17 | 61 | F | Yes | 20 | 101 | 7.8 | 2550 | - |
Mean ± SD | 50.5 ± 8.05 |  |  | 12 ± 7.15 | 156.25 ± 95.35 | 8.85 ± 2.43 |  |  |
GDM-09 | 33 | F | No | Â | 80 | 5 | - | 35 |
GDM-10 | 29 | F | Yes | Â | 89 | 5.8 | - | 37 |
GDM-12 | 39 | F | No | Â | 72 | 5.7 | - | 32 |
GDM-13 | 29 | F | Yes | Â | 92 | 5.2 | - | 28 |
GDM-14 | 30 | F | No | Â | 82 | 5 | - | 34 |
GDM-16 | 38 | F | Yes | Â | 59 | 9.1 | - | 34 |
Mean ± SD | 33 ± 4.51 |  |  |  | 79 ± 12.06 | 5.96 ± 1.57 |  | 33.33 ± 3.07 |